“…>20 C) n-3 polyunsaturated fatty acids (PUFAs), primarily eicosapentaenoic acid (EPA; 20:5 n-3) and docosahexaenoic acid (DHA; 22:6 n-3), are beneficial in the context of lowering cardiovascular disease morbidity and mortality (Walker et al, 2013;Maehre et al, 2015). Dietary VLC n-3 supplementation may also improve inflammatory conditions, such as rheumatoid arthritis (Calder, 2006;Spite, 2013), cognitive function (Flock et al, 2013;Huhn et al, 2015), and visual acuity of preterm children (Molloy et al, 2012).…”